In conclusion, in this high-risk histology cohort, patients with L1CAM positive had a worse prognosis similar to p53-aberrant tumours, and the combination of p53ab/L1CAMpos showed an even higher risk of progression and death compared to p53wt/L1CAMneg. The gene discussed is TP53; the disease is neoplasm.